TG Therapeutics (TGTX) Misses Q4 EPS by 22c
TG Therapeutics (NASDAQ: TGTX) reported Q4 EPS of ($0.48), $0.22 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.
TG Therapeutics (NASDAQ: TGTX) reported Q4 EPS of ($0.48), $0.22 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.